Curran Simpson
Net worth: 321 128 $ as of 2026-05-30
Net worth: 321 128 $ as of 2026-05-30
Curran M.
Simpson currently works at REGENXBIO, Inc., as President, Chief Executive Officer & Director from 2024 and Alliance for Regenerative Medicine, as Director.
Mr. Simpson also formerly worked at Biogen MA, Inc., as Director-Manufacturing Sciences from 2001 to 2003, Covance Biotechnology Services, Inc., as Engineering Director from 1999 to 2001, Genentech, Inc., as Senior Research Engineer from 1992 to 1995, Nalco Chemical Co., as Senior Chemist from 1985 to 1987, Genencor International, Inc., as Senior Scientist-Development from 1987 to 1992, GSK Plc, as COO & Head-North American Supply Chain from 2012 to 2015, Novo-Nordisk Biochem, Inc., as Manager-Pilot Plant North America Division from 1995 to 1997, and Human Genome Sciences, Inc., as Senior Vice President-Operations from 2006 to 2012.
Mr. Simpson received his undergraduate degree from Clarkson College and graduate degree from Clarkson University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
REGENXBIO, INC. 0.09% | 2026-03-31 | 45,810 ( 0.09% ) | 321 128 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| REGENXBIO INC. | Chief Executive Officer | 2024-06-30 |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
| GSK PLC | Chief Operating Officer | 2015-07-31 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Chief Operating Officer | 2012-11-30 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Develops and manufactures drugs related to immunology, neurobiology and oncology | Corporate Officer/Principal | 2002-12-31 |
Covance Biotechnology Services, Inc.
Covance Biotechnology Services, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Corporate Officer/Principal | 2000-12-31 |
Novo-Nordisk Biochem, Inc. | Corporate Officer/Principal | 1996-12-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 12 |
|---|---|
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Develops and manufactures drugs related to immunology, neurobiology and oncology | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Nalco Chemical Co.
Nalco Chemical Co. Chemicals: SpecialtyProcess Industries Produces and sells chemicals and systems used in water treatment and pollution control | Process Industries |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Health Technology |
Genencor International, Inc.
Genencor International, Inc. BiotechnologyHealth Technology Develops and manufactures enzyme product solutions | Health Technology |
REGENXBIO, Inc.
REGENXBIO, Inc. Pharmaceuticals: MajorHealth Technology Develops gene therapy | Health Technology |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Covance Biotechnology Services, Inc.
Covance Biotechnology Services, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Clarkson College
Clarkson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clarkson University
Clarkson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novo-Nordisk Biochem, Inc. | |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Select your edition
All financial news and data tailored to specific country editions